Institutional Ownership Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX). We have compiled data on the 188 institutions that hold shares in the stock, with a total of 69.3 Million shares, which have been reported (via 13F filing form) to have a value of $1.45 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
8,354,151
shares
|
$171 Million
0.03% of portfolio
|
Q1 2025
New holding
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2025 Q1 2025 |
6,500,000
shares
|
$133 Million
9.94% of portfolio
|
Q1 2025
Added 28.35%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,690,761
shares
|
$96.1 Million
0.0% of portfolio
|
Q2 2024
Added 3.96%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
3,898,435
shares
|
$79.9 Million
0.0% of portfolio
|
Q1 2025
Added 0.42%
|
|
Eventide Asset Management, LLC
Boston, MA |
May 15, 2025 Q1 2025 |
3,754,793
shares
|
$76.9 Million
1.45% of portfolio
|
Q1 2025
Added 0.04%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
3,410,499
shares
|
$69.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 4.12%
|
|
Commodore Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
3,200,000
shares
|
$65.6 Million
5.69% of portfolio
|
Q1 2025
New holding
|
|
Bellevue Group Ag
Kuesnacht, V8 |
May 14, 2025 Q1 2025 |
3,071,615
shares
|
$62.9 Million
1.29% of portfolio
|
Q3 2024
Added 3.37%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,806,359
shares
|
$57.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 13.25%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
2,621,175
shares
|
$53.7 Million
0.12% of portfolio
|
Q1 2025
Added 4.18%
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
2,000,000
shares
|
$41 Million
1.27% of portfolio
|
Q1 2025
Added 29.86%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,794,048
shares
|
$36.8 Million
0.07% of portfolio
|
Q2 2023
Added 130.12%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,589,806
shares
|
$32.6 Million
0.0% of portfolio
|
Q1 2025
Added 3.58%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
1,468,240
shares
|
$30.1 Million
0.01% of portfolio
|
Q1 2025
Added 276.67%
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2025 Q1 2025 |
1,403,435
shares
|
$28.8 Million
0.17% of portfolio
|
Q1 2025
Reduced 10.37%
|
|
Novo Holdings
Hellerup, G7 |
May 15, 2025 Q1 2025 |
1,200,000
shares
|
$24.6 Million
1.96% of portfolio
|
Q1 2025
Added 20.0%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
1,188,429
shares
|
$24.4 Million
0.15% of portfolio
|
Q1 2025
Reduced 40.99%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
957,794
shares
|
$19.6 Million
0.02% of portfolio
|
Q1 2025
Reduced 12.14%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
902,882
shares
|
$18.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 32.83%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
May 14, 2025 Q1 2025 |
871,628
shares
|
$17.9 Million
0.01% of portfolio
|
Q1 2025
Added 92.63%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
812,653
shares
|
$16.7 Million
0.88% of portfolio
|
Q1 2025
Reduced 33.51%
|
|
Eversept Partners, LP
New York, NY |
May 15, 2025 Q1 2025 |
696,499
shares
|
$14.3 Million
1.4% of portfolio
|
Q1 2025
Reduced 3.24%
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
696,007
shares
|
$14.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 42.12%
|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
625,321
shares
|
$12.8 Million
0.01% of portfolio
|
Q1 2025
Added 2.77%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
603,401
shares
|
$12.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 14.78%
|